We've been troubled by the
Food and Drug Administration (FDA)'s movements of late
because the direction the agency seems to be heading seems to be to make
medicine harder to approve -when patients need it most! The drugs out there
represent great strides, but with eight million people in the US alone with
A1cs over 7 and with many people that have medicine that doesn't work anymore,
some innovation would be welcome. We of course want all the innovation to be
safe! That is the top priority. But we worry that development of new therapy
will slow down at a time when more is needed. See Diabetes Mine today where Amy talks to an eloquent diabetes
advocate Rebecca Killion, who has also sat on FDA committees, notably one last
July where she found some comments at the meeting worrying. We have the idea of
giving more patient input to the FDA - if you agree, please sign our petition
at healthefda.com. This is an important time with a new FDA commissioner to be
announced shortly - show them how much we care about patient input by signing
the petition and sending to your friends and family. In our view, more patient
input would be a win-win all the way around.
-Kelly Close
Comments